| Boronic ester-linked macrocyclic lipopeptides as serine protease inhibitors targeting Escherichia coli type I signal peptidase N Szałaj, L Lu, A Benediktsdottir, E Zamaratski, S Cao, G Olanders, ... European Journal of Medicinal Chemistry 157, 1346-1360, 2018 | 17 | 2018 |
| Design, synthesis and in vitro biological evaluation of oligopeptides targeting E. coli type I signal peptidase (LepB) M De Rosa, L Lu, E Zamaratski, N Szałaj, S Cao, H Wadensten, ... Bioorganic & Medicinal Chemistry 25 (3), 897-911, 2017 | 17 | 2017 |
| Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation A Benediktsdottir, L Lu, S Cao, E Zamaratski, A Karlén, SL Mowbray, ... European Journal of Medicinal Chemistry 224, 113699, 2021 | 11 | 2021 |
| Synthesis and In Vitro Biological Evaluation of Quinolinyl Pyrimidines Targeting Type II NADH-Dehydrogenase (NDH-2) L Lu, L Åkerbladh, S Ahmad, V Konda, S Cao, A Vocat, L Maes, ST Cole, ... ACS Infectious Diseases 8 (3), 482-498, 2022 | 2 | 2022 |
| Structural and Biochemical Characterizations of Three Potential Drug Targets from Pathogens L Lu Acta Universitatis Upsaliensis, 2021 | | 2021 |
| MEPicides: α, β-Unsaturated Fosmidomycin N-acyl Analogsas inhibitors that selectively target DXR from Plasmodium falciparum, the deadliest causative parasite of human Malaria L Lu, X Wang, RL Edwards, S Sooriyaarachchi, A Haymond, T Bergfors, ... | | 2021 |
| Novel macrocyclic lipopeptides as serine protease inhibitors targeting Escherichia coli type I signal peptidase A Benediktsdottir, NN Szalaj, L Lu, E Zamaratski, S Cao, G Olanders, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
| Synthesis and in vitro biological evaluation of quinolinyl pyrimidines targeting type II NADH-dehydrogenase (NDH-2) L Åkerbladh, L Lu, K Konda, S Cao, A Vocat, L Maes, ST Cole, D Hughes, ... | | 2017 |
